-
Product Insights
NewStreptococcal Pneumonia – Drugs In Development, 2024
Empower your strategies with our Streptococcal Pneumonia – Drugs In Development, 2024 report and make more profitable business decisions. Streptococcus pneumoniae, or pneumococcus, is a Gram-positive spherical bacteria, and alpha-hemolytic member of the genus Streptococcus. Pneumococcal infections are present throughout the world and are most common during the winter and early spring months. Pneumoniae is prevalent in large part due to its colonizing ability in the nasopharynx. Almost 40-50% healthy children and 20-30% of healthy adults are carriers. With childhood conjugate...
-
Product Insights
Clinical Decision Support Systems Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Clinical Decision Support Systems Pipeline Market Report Overview The Clinical Decision Support Systems (CDSS) are software tools that assist healthcare professionals with decision-making. The software consolidates a medical knowledge base with patient information to produce case-specific advice. The Clinical Decision Support Systems pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the...
-
Company Insights
Insurance Australia Group – Digital Transformation Strategies
Insurance Australia Group (IAG) Digital Transformation Strategies Report Overview Insurance Australia Group (IAG) is tapping into key disruptive technologies, including AI, big data, cloud, and cybersecurity, among others, to digitally transform its operations. The annual ICT spending of IAG is estimated at $215.9 million for 2023. A major share of this spending is earmarked for acquiring software, network and communications, and hardware from vendors. IAG is a general insurance company operating in Australia and New Zealand. In Australia, the company’s...
-
Track & Monitor
Innovation in pharma: miRNA modulation
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the pharma industry’s miRNA modulation segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered based on...
-
Track & Monitor
Innovation in Pharmaceuticals: LPS antibody-based anti-bacterials
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the Pharmaceuticals industry’s LPS antibody-based anti-bacterials segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered based...
-
Product Insights
Max Planck – Garching Max Planck Institute for Physics – Bavaria
Equip yourself with the essential tools needed to make informed and profitable decisions with our Max Planck - Garching Max Planck Institute for Physics - Bavaria report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Product Insights
Max Planck Soc – Halle Max Planck Institute Research Center – Saxony-Anhalt
Equip yourself with the essential tools needed to make informed and profitable decisions with our Max Planck Soc - Halle Max Planck Institute Research Center - Saxony-Anhalt report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Product Insights
Implantable Cardioverter Defibrillators (ICD) Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Implantable Cardioverter Defibrillators (ICD) Pipeline Market Report Overview An implantable cardioverter defibrillator (ICD) is an electronic device that monitors the heart’s rhythm and delivers electric pulses if it detects an arrhythmia (irregular heartbeat) to restore the heart’s natural rhythm. The ICD pipeline market research report provides comprehensive information about the Implantable Cardioverter Defibrillators (ICD) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
-
Product Insights
Cardiac Rhythm Management Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Cardiac Rhythm Management Devices Pipeline Market Report Overview Cardiac Rhythm Management (CRM) devices are those devices which are used to restore the natural synchronized pumping rhythm of the heart. These include Pacemakers, Cardiac Resynchronisation Therapy (CRT), Implantable Loop Recorders and Implantable Cardioverter Defibrillators (ICD). These devices are used for the treatment of congestive heart failure. The Cardiac Rhythm Management Devices pipeline market research report provides comprehensive information about the Cardiac Rhythm Management Devices pipeline products with comparative analysis of the...
-
Track & Monitor
Innovation in Pharmaceuticals: miRNA chemical synthesis
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the Pharmaceuticals industry’s miRNA chemical synthesis segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered based...